DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gammagard S / D (Immune Globulin Intravenous) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Gammagard S / D (Immune Globulin Intravenous) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Gammagard S / D side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-27

Patient: 62 year old female

Reactions: Agitation, Personality Change, Dysphagia, Hallucination, Auditory, Cerebellar Syndrome, Facial Pain, Blood Lactic Acid Increased, Chronic Lymphocytic Leukaemia, Hyperproteinaemia, Neoplasm Recurrence, Optic Neuropathy, Insomnia, Toxic Neuropathy, Blood Creatinine Increased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2003-01-01
    End date: 2006-05-01

Cyclophosphamide
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2009-04-01
    End date: 2009-04-01

Gammagard S / D
    Indication: Hypogammaglobulinaemia
    Start date: 2009-02-01

Cyclophosphamide
    Administration route: Oral
    Start date: 2009-01-06
    End date: 2009-01-01

Fludarabine Phosphate
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2009-04-01
    End date: 2009-04-01

Fludarabine Phosphate
    Administration route: Oral
    Start date: 2009-02-25
    End date: 2009-02-01

Fludarabine Phosphate
    Start date: 2010-04-17
    End date: 2010-04-21

Fludarabine Phosphate
    Administration route: Oral
    Start date: 2009-01-06
    End date: 2009-01-01

Mabthera
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2009-01-06
    End date: 2009-04-03

Cyclophosphamide
    Administration route: Oral
    Start date: 2009-02-25
    End date: 2009-02-01

Fludarabine Phosphate
    Start date: 2005-11-01
    End date: 2006-05-01

Other drugs received by patient: Vincristine; Doxorubicin HCL; Antilymphocyte Serum; Cyclosporine; Octagam; Busulfan; Prednisolone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017